HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,272.00
0.00 (0.00%)
At close: Feb 19, 2026

HLB bioStep Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
23,04246,17468,79914,8736,1588,040
Short-Term Investments
-686.981,57855,000-2,550
Trading Asset Securities
---27,1914,2354,320
Cash & Short-Term Investments
23,04246,86170,37797,06410,39314,910
Cash Growth
-50.45%-33.41%-27.49%833.97%-30.30%-7.98%
Accounts Receivable
5,8987,4833,7307,0097,7886,800
Other Receivables
214.691,035337.142,738662.43580.36
Receivables
6,3698,9004,46910,06510,1538,829
Inventory
1,5651,5111,5511,6502,9202,341
Prepaid Expenses
1,467132.68249133.9710.398.75
Other Current Assets
17,6315,0732,767512.375,5202,490
Total Current Assets
50,07362,47879,413109,42628,99628,579
Property, Plant & Equipment
51,04752,09440,67839,62639,86726,226
Long-Term Investments
30,80137,68744,91612,81115,05112,287
Goodwill
6,4906,4901,0491,0491,2531,253
Other Intangible Assets
3,0243,485750.69811.65722.08643.24
Long-Term Deferred Tax Assets
3,3963,1001,0962,1271,302912.09
Other Long-Term Assets
10,8612,2742,8416,3167,4143,495
Total Assets
156,412168,329171,714172,18794,62674,215
Accounts Payable
1,4311,9041,5732,0501,6481,356
Accrued Expenses
593.73675.07438.93533.51324.38282.67
Short-Term Debt
24,44628,64454,3161,6891,189210
Current Portion of Long-Term Debt
3,7483,7483,4483,2243,0003,000
Current Portion of Leases
353.91414.96367.28398.72841.66696.08
Current Income Taxes Payable
-3.1119.77352.861,444674.94
Other Current Liabilities
8,12810,8964,5184,5278,1349,159
Total Current Liabilities
38,70146,28564,68212,77516,58215,379
Long-Term Debt
1,1211,5692,01785,91110,6902,690
Long-Term Leases
413.63320.38487.93418.11583910.01
Pension & Post-Retirement Benefits
1,7141,541310.49126.46259.14184.45
Other Long-Term Liabilities
2,2881,800643.61753.88151.0328.07
Total Liabilities
44,23751,51568,14199,98428,26519,191
Common Stock
8,7018,6737,8637,053765.19761.94
Additional Paid-In Capital
85,95284,86160,10431,82729,66128,608
Retained Earnings
19,68023,26530,72731,36634,47624,585
Treasury Stock
-7,332-7,332-1,422---960.15
Comprehensive Income & Other
910.022,4074,31830.94-315.38648.22
Total Common Equity
107,911111,874101,59070,27864,58753,643
Minority Interest
4,2644,9401,9831,9251,7741,381
Shareholders' Equity
112,175116,814103,57372,20266,36155,024
Total Liabilities & Equity
156,412168,329171,714172,18794,62674,215
Total Debt
30,08334,69660,63791,64116,3047,506
Net Cash (Debt)
-7,04112,1659,7405,424-5,9117,404
Net Cash Growth
-24.90%79.57%---20.64%
Net Cash Per Share
-92.74141.83126.9677.48-84.46107.21
Filing Date Shares Outstanding
84.4784.278.1370.5368.8767.93
Total Common Shares Outstanding
84.4784.278.1370.5368.8768.57
Working Capital
11,37216,19314,73196,65112,41413,200
Book Value Per Share
1277.501328.741300.35996.42937.86782.27
Tangible Book Value
98,397101,89999,79068,41762,61251,747
Tangible Book Value Per Share
1164.871210.271277.31970.03909.17754.61
Land
27,57627,57615,25315,25313,4179,744
Buildings
31,00530,98524,97424,28023,32712,312
Construction In Progress
77.6540989.4-511.282,631
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.